1999
DOI: 10.1128/mcb.19.8.5363
|View full text |Cite|
|
Sign up to set email alerts
|

Purification and Identification of p68 RNA Helicase Acting as a Transcriptional Coactivator Specific for the Activation Function 1 of Human Estrogen Receptor α

Abstract: The estrogen receptor (ER) regulates the expression of target genes in a ligand-dependent manner. The ligand-dependent activation function AF-2 of the ER is located in the ligand binding domain (LBD), while the N-terminal A/B domain (AF-1) functions in a ligand-independent manner when isolated from the LBD. AF-1 and AF-2 exhibit cell type and promoter context specificity. Furthermore, the AF-1 activity of the human ERalpha (hERalpha) is enhanced through phosphorylation of the Ser(118) residue by mitogen-activa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

14
287
1
1

Year Published

2000
2000
2011
2011

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 333 publications
(303 citation statements)
references
References 53 publications
14
287
1
1
Order By: Relevance
“…Our study identified two new tyrosine phosphorylation sites for cAbl, Tyr-52 and Tyr-219 (Figures 2c-d). In general, phosphorylation of serine residues in the AF1 domain of ERa seems to influence the recruitment of coactivators, resulting in enhanced ER-mediated transcription (Deborah, 2003;Tremblay et al, 1999;Endoh et al, 1999). Phosphorylation of tyrosine 537 leads to increased ligand-independent transcriptional activation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Our study identified two new tyrosine phosphorylation sites for cAbl, Tyr-52 and Tyr-219 (Figures 2c-d). In general, phosphorylation of serine residues in the AF1 domain of ERa seems to influence the recruitment of coactivators, resulting in enhanced ER-mediated transcription (Deborah, 2003;Tremblay et al, 1999;Endoh et al, 1999). Phosphorylation of tyrosine 537 leads to increased ligand-independent transcriptional activation.…”
Section: Discussionmentioning
confidence: 99%
“…Most of the ERa coactivators binding to the AF-2 region of ERa have been shown to increase ERa transcriptional activity in a ligand-dependent manner. Recently, a few coactivators interact with the AF-1 or DBD region and regulate ERa transcriptional activity in a ligand-independent manner (Chakravarti et al, 1996;Yao et al, 1996;Weigel and Zhang, 1998;Alen et al, 1999;Endoh et al, 1999;Xu et al, 1999;Ding et al, 2003). Given that c-Abl does not interact with ERa P79,333A, the ligand-independent ERa transactivation by c-Abl seems to involve the AF-1 and AF-2 domains, especially the AF1 domain.…”
Section: Discussionmentioning
confidence: 99%
“…DDX20 represses transcription, probably through the recruitment of histone deacetylases 134 . p68 and p72 are transcriptional coactivator s for nuclear oestrogen receptor-α (ERα) 135,136 , and p68 also acts as a potent co-activator of the tumour suppressor p53 (REF. 137).…”
Section: Next-generation Sequencingmentioning
confidence: 99%
“…137). Although the interacting region between p68 and p72 and ERα includes part of the conserved helicase core and RNA binding is important for ERα co-activation, p68 helicase activity per se is not required 135,136 . Clearly, these activities are not the general rule and further work is required to elucidate how these roles are fulfilled and whether other DEAD box proteins display similar activities.…”
Section: Next-generation Sequencingmentioning
confidence: 99%
“…Estradiol (E 2 ) modifies the effect of the IGF-1 pathway by upregulating the expression of several components of the pathway including the insulin-like growth factor 1 receptor (IGF1R), insulin receptor substrate 1 (IRS-1), and IGF binding proteins (IGFBPs) [11,[15][16][17]. Conversely, the insulin and IGF-1 pathways have been shown to induce ER phosphorylation and therefore receptor activity through a phosphatidylinositol 3-kinase (PI3-kinase) or extracellular signalregulated (ERK-mediated) mechanism [12,[18][19][20]. It also has been shown through in vitro assays, that co-administration of estrogen and growth factors to cells has synergistic effects on proliferation compared to either treatment alone [11,12]; however, the exact mechanism of this synergy has not been resolved.…”
Section: Introductionmentioning
confidence: 99%